and medical director of the pancreatic islet cell transplant program at University of Pennsylvania Perelman School of Medicine, presented additional data from 14 adult participants in the phase 1/ ...

A research team has successfully developed an innovative platform for diabetes treatment using bioink derived from pancreatic ...

of ongoing type 1 diabetes study showing that hypoimmune-modified pancreatic islet cells transplanted without immunosuppression overcome autoimmune and allogeneic immune recognition, function, and ...

Sana revolutionizes treatments for diabetes, cancer, and autoimmune diseases. SANA has high cash burn and dilution risks. See ...

Eledon Pharmaceuticals has revealed that two patients with type 1 diabetes achieved a 'functional cure' after receiving a transplant of insulin-producing islet cells in combination with its ...

Diabetes is a metabolic disorder caused by dysfunction in the pancreas, the organ responsible for regulating blood sugar levels. Within the pancreas, islet cells secrete insulin to lower blood sugar.

Tegoprubart used as a key component of immunosuppression regimen in the second transplant of a genetically modified pig kidney into a human conducted at Massachusetts General Hospital Announced positi ...

Islet cells regulate insulin secretion through ... and improving the efficiency of islet transplantation therapies." This work was supported by the National Research Foundation of South Korea ...

Researchers have found that some cells form new multicellular structures with functions that defy their original biological ...

also recently reported positive results with its Cell Pouch islet cell transplant system, including insulin independence of between six and 38 months in five of the first recipients of the therapy.